PAVmed PAVM
NASDAQ PAVM
$2.17 +0.12 (+5.85%)
At close: Oct 23, 2026 · 4:00 PM EDT

PAVmed (PAVM) Gains from Sales and Divestitures (2023)

Updated

PAVmed (PAVM) reported Gains from Sales and Divestitures of $1 million for FY2023.

Analysis

PAVmed (PAVM) Gains from Sales and Divestitures (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 249.17 Bn 228.32 Bn 4.88 Bn
2 Abbott Laboratories 179.42 Bn 150.51 Bn 7.27 Bn
3 Danaher 161.98 Bn 145.80 Bn 3.61 Bn
4 Intuitive Surgical 156.76 Bn 137.18 Bn 2.08 Bn
5 Medtronic 122.13 Bn 88.00 Bn 6.34 Bn
6 Stryker 117.84 Bn 103.96 Bn 4.50 Bn
7 Boston Scientific 66.19 Bn 61.20 Bn 3.85 Bn
8 Becton Dickinson 54.16 Bn 51.31 Bn 2.32 Bn
9 Edwards Lifesciences 51.35 Bn 35.47 Bn 1.35 Bn
10 PAVmed 50.78 Mn 22.61 Mn -89,000.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 1.00 Mn
API Access

PAVmed Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=PAVM&period=max&api_key=YOUR_API_KEY